Gilead Sciences receives European Commission marketing authorisation for Truvada
Gilead Sciences receives European Commission marketing authorisation for Truvada
About this item
Full title
Gilead Sciences receives European Commission marketing authorisation for Truvada
Publisher
London: Normans Media Ltd
Journal title
M2 Pharma, 2016
Language
English
Formats
Publication information
Publisher
London: Normans Media Ltd
Subjects
More information
Scope and Contents
Contents
M2PHARMA-August 24, 2016-Gilead Sciences receives European Commission marketing authorisation for Truvada (C)2016 M2 COMMUNICATIONS http://www.m2.com Gilead Sciences, a United States-based biopharmaceutical company, has received marketing authorisation from the European Commission for its once-daily T...
Alternative Titles
Full title
Gilead Sciences receives European Commission marketing authorisation for Truvada
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_1813584192
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1813584192
How to access this item
Log in as a Library member
